Literature DB >> 11399992

First CRF01_AE/B recombinant of HIV-1 is found in Thailand.

S Tovanabutra1, V Polonis, M De Souza, R Trichavaroj, P Chanbancherd, B Kim, E Sanders-Buell, S Nitayaphan, A Brown, M R Robb, D L Birx, F E McCutchan, J K Carr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11399992     DOI： 10.1097/00002030-200105250-00018

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

1.  Identification of a novel HIV type 1 circulating recombinant form (CRF52_01B) in Southeast Asia.

Authors:  Yongjian Liu; Lin Li; Zuoyi Bao; Hanping Li; Daomin Zhuang; Siyang Liu; Xiaolin Wang; Tianyi Li; Lei Jia; Shaomin Yang; Jingyun Li
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-05       Impact factor: 2.205

2.  RecDraw: a software package for the representation of HIV-1 recombinant structures.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Chris Beyrer; Eric E Sanders-Buell; Miguel A Arroyo; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

3.  Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia.

Authors:  Wei Zhen Chow; Haider Al-Darraji; Yeat Mei Lee; Yutaka Takebe; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

4.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

5.  CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Authors:  Awet Abraha; Immaculate L Nankya; Richard Gibson; Korey Demers; Denis M Tebit; Elizabeth Johnston; David Katzenstein; Asna Siddiqui; Carolina Herrera; Lucia Fischetti; Robin J Shattock; Eric J Arts
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions.

Authors:  Jennifer L Troyer; Jill Pecon-Slattery; Melody E Roelke; Lori Black; Craig Packer; Stephen J O'Brien
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 8.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

9.  Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3'-azido-3'-deoxythymidine.

Authors:  Krista A Delviks-Frankenberry; Galina N Nikolenko; Frank Maldarelli; Saiki Hase; Yutaka Takebe; Vinay K Pathak
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

10.  Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters.

Authors:  Wei Zhen Chow; Lai Yee Ong; Siti Humaira Razak; Yeat Mei Lee; Kim Tien Ng; Yean Kong Yong; Azureen Azmel; Yutaka Takebe; Haider Abdulrazzaq Abed Al-Darraji; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.